On the other hand, PI3K/AKT antagonizes TGFbeta-induced cytostatic responses and causes the shift in TGFbeta/SMAD signaling to its tumor-promoting mode during malignant tumor progression, thus indicating the existence of a signaling interplay between TGFbeta and PI3K/AKT pathways. Here, AKT1 is linked to neoplasm.